Dr. Scott Gottlieb warned Thursday in regards to the potential for long-term mind loss related to Covid, citing a new research from the UK.
“In brief, the research means that there might be some long-term lack of mind tissue from Covid, and that might have some long-term penalties,” the previous FDA chief and CNBC contributor mentioned.
“You might compensate for that over time, so the signs of that will go away, however you are by no means going to regain the tissue if, in actual fact, it is being destroyed on account of the virus,” mentioned Gottlieb, who serves on the board of Covid vaccine-maker Pfizer.
The U.Ok. research examined mind imaging earlier than and after a coronavirus an infection and seemed particularly on the potential impact on the nervous system.
Gottlieb defined to CNBC’s “The Information with Shepard Smith” that the destruction of mind tissue may clarify why Covid sufferers misplaced their sense of odor.
“The diminishment within the quantity of cortical tissue occurred to be in areas of the mind which are near the locations which are accountable for odor,” he mentioned. “What it suggests is that, the odor, the lack of odor, is simply an impact of a extra main course of that is underway, and that course of is definitely shrinking of cortical tissue.”
Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech firm Aetion Inc. and biotech firm Illumina.